Keyphrases
Magnetic Resonance Imaging
100%
Pediatric Population
100%
Gastrointestinal
100%
Perflubron
100%
Imaging Contrast Agents
100%
Bowel
60%
T2-weighted Imaging (T2WI)
40%
Vital Signs
40%
Contrast Imaging
40%
Proton Density Weighted Image
40%
Adverse Effects
20%
Liver
20%
Adverse Events
20%
Multicenter Trial
20%
Abdominal
20%
Pelvis
20%
Pancreas
20%
Abdomen
20%
Improvement Factor
20%
Clinical Laboratory
20%
Digestive System
20%
Post-contrast
20%
T1-weighted Image
20%
Orally Administered
20%
Left Temporal Lobe
20%
Pulse Sequence
20%
Density Weight
20%
MR Contrast Agents
20%
T2-weighted Sequences
20%
Pathological Tissue
20%
Efficacy Analysis
20%
Pelvic Region
20%
Laboratory Signs
20%
Pediatric Subjects
20%
Proton Density
20%
Mesenteric Fat Tissue
20%
Routine Laboratory Parameters
20%
Medicine and Dentistry
Pediatrics
100%
Magnetic Resonance Imaging
100%
Contrast Medium
100%
Perflubron
100%
Pelvis
40%
Vital Sign
40%
Adverse Event
20%
Tail
20%
Ingestion
20%
Digestive System
20%
Pulse Sequence
20%
Pathological Tissue
20%
Mesenteric Fat
20%
Magnetic Resonance Contrast Agent
20%
Adverse Effect
20%
Neuroscience
Magnetic Resonance Imaging
100%
Pelvis
100%
Contrast Medium
100%
Adverse Effect
50%
Magnetic Resonance Contrast Agent
50%
Pulse Sequence
50%
Digestive System
50%
Agricultural and Biological Sciences
Pelvis
100%
Pancreas
50%
Tail
50%
Adverse Effects
50%
Digestive System
50%
Ingestion
50%
Pharmacology, Toxicology and Pharmaceutical Science
Contrast Medium
100%
Perfluorooctyl Bromide
100%
Adverse Event
20%
Magnetic Resonance Contrast Agent
20%